FR2122325B2 - - Google Patents

Info

Publication number
FR2122325B2
FR2122325B2 FR7101815A FR7101815A FR2122325B2 FR 2122325 B2 FR2122325 B2 FR 2122325B2 FR 7101815 A FR7101815 A FR 7101815A FR 7101815 A FR7101815 A FR 7101815A FR 2122325 B2 FR2122325 B2 FR 2122325B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7101815A
Other languages
French (fr)
Other versions
FR2122325A2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAES ROLAND BE
Original Assignee
MAES ROLAND BE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAES ROLAND BE filed Critical MAES ROLAND BE
Priority to FR7101815A priority Critical patent/FR2122325A2/fr
Publication of FR2122325A2 publication Critical patent/FR2122325A2/fr
Application granted granted Critical
Publication of FR2122325B2 publication Critical patent/FR2122325B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7101815A 1971-01-20 1971-01-20 Polynucleic acid/polycationic compounds - for potentiating antiviral vaccines Granted FR2122325A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7101815A FR2122325A2 (en) 1971-01-20 1971-01-20 Polynucleic acid/polycationic compounds - for potentiating antiviral vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7101815A FR2122325A2 (en) 1971-01-20 1971-01-20 Polynucleic acid/polycationic compounds - for potentiating antiviral vaccines

Publications (2)

Publication Number Publication Date
FR2122325A2 FR2122325A2 (en) 1972-09-01
FR2122325B2 true FR2122325B2 (OSRAM) 1974-08-23

Family

ID=9070579

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7101815A Granted FR2122325A2 (en) 1971-01-20 1971-01-20 Polynucleic acid/polycationic compounds - for potentiating antiviral vaccines

Country Status (1)

Country Link
FR (1) FR2122325A2 (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2328479A1 (fr) * 1975-10-22 1977-05-20 Beecham Group Ltd Substance antivirale
WO1979000515A1 (en) * 1978-01-16 1979-08-09 Univ Boston Method of effecting cellular uptake of molecules
AU4690596A (en) * 1994-12-30 1996-07-24 Chiron Viagene, Inc. Nucleic acid condensing agents with reduced immunogenicity

Also Published As

Publication number Publication date
FR2122325A2 (en) 1972-09-01

Similar Documents

Publication Publication Date Title
AU2658571A (OSRAM)
AU2691671A (OSRAM)
AU2952271A (OSRAM)
AU2726271A (OSRAM)
AU2485671A (OSRAM)
AU2564071A (OSRAM)
AU2684071A (OSRAM)
AU2742671A (OSRAM)
AU2894671A (OSRAM)
AU3005371A (OSRAM)
AU2941471A (OSRAM)
AU2836771A (OSRAM)
AU2706571A (OSRAM)
AU2940971A (OSRAM)
AU2938071A (OSRAM)
AU2930871A (OSRAM)
AU2927871A (OSRAM)
AU3025871A (OSRAM)
AU2473671A (OSRAM)
AU2885171A (OSRAM)
AU2880771A (OSRAM)
AU2875571A (OSRAM)
AU2854371A (OSRAM)
AU2837671A (OSRAM)
AU2907471A (OSRAM)

Legal Events

Date Code Title Description
TP Transmission of property
GC Lien (pledge) constituted